Why Applied DNA Sciences Is Up 80% Today

Loading...
Loading...

Applied DNA Sciences APDN shares are trading higher after the company published a press release highlighting the FDA's findings on sensitivities in specific COVID-19 tests. The company says its' Linea COVID-19 Assay Kit is '1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7).'

Applied DNA Sciences is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Applied DNA Sciences shares were trading up 80% to $10.33 at publication time. The stock has a 52-week high of $16.39 and a 52-week low of $2.52.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsHealth CareFDAGeneralCoronavirusCovid-19
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...